Also interesting
Cell Matters acquired by global leader Cryoport
After a strategic partnership to deliver end-to-end cryopreservation services for leukapheresis derived therapies, Cryoport acquired Cell Matters.
GSK continues to invest heavily in Belgium at its sites in Wavre and Rixensart
The British pharmaceutical company GSK continues to invest in its production site in Wavre and its research and development site in Rixensart...
Kaneka Eurogentec receives GMP accreditation for new mRNA manufacturing facility – COVID-19 vaccine production ongoing
The new facility audited and accredited by Belgian Authorities will allow the production and the purification of up to 10 g scale ( up to 1 Million doses of vaccine)...